Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Rueda

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|December 23, 2016
Targeting the Brain with NanomedicineFelix Rueda, Luis J Cruz
Biomaterials|January 23, 2016
Combinatorial prospects of nano-targeted chemoimmunotherapyC G Da Silva, Felix Rueda, C W Löwik, et al.
Nanomedicine (London, England)|June 10, 2014
Liposomes containing NY‑ESO‑1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccinesLuis J Cruz, Felix Rueda, Lorena Simón, et al.
Nanomedicine (London, England)|November 15, 2012
Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cellsLuis J Cruz, Felix Rueda, Paul Tacken, et al.
Nanomedicine (London, England)|February 10, 2017
Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicityLuis J Cruz, Paul J Tacken, Christina Eich, et al.
Methods in Enzymology|May 10, 2012
Targeting nanoparticles to dendritic cells for immunotherapyLuis J Cruz, Paul J Tacken, Felix Rueda, et al.
Molecular Pharmaceutics|December 3, 2010
Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapyLuis J Cruz, Felix Rueda, Begoña Cordobilla, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 29, 2014
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative studyLuis J Cruz, Rodney A Rosalia, Jan Willem Kleinovink, et al.
Immunobiology|June 19, 2017
Effect of TLR ligands co-encapsulated with multiepitopic antigen in nanoliposomes targeted to human DCs via Fc receptor for cancer vaccinesFelix Rueda, Christina Eich, Begoña Cordobilla, et al.
Molecules (Basel, Switzerland)|May 15, 2019
ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-PresentationLuis J Cruz, Paul J Tacken, Johan M S van der Schoot, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|December 23, 2016
Targeting the Brain with NanomedicineFelix Rueda, Luis J Cruz
Biomaterials|January 23, 2016
Combinatorial prospects of nano-targeted chemoimmunotherapyC G Da Silva, Felix Rueda, C W Löwik, et al.
Nanomedicine (London, England)|June 10, 2014
Liposomes containing NY‑ESO‑1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccinesLuis J Cruz, Felix Rueda, Lorena Simón, et al.
Nanomedicine (London, England)|November 15, 2012
Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cellsLuis J Cruz, Felix Rueda, Paul Tacken, et al.
Nanomedicine (London, England)|February 10, 2017
Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicityLuis J Cruz, Paul J Tacken, Christina Eich, et al.
Methods in Enzymology|May 10, 2012
Targeting nanoparticles to dendritic cells for immunotherapyLuis J Cruz, Paul J Tacken, Felix Rueda, et al.
Molecular Pharmaceutics|December 3, 2010
Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapyLuis J Cruz, Felix Rueda, Begoña Cordobilla, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 29, 2014
Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative studyLuis J Cruz, Rodney A Rosalia, Jan Willem Kleinovink, et al.
Immunobiology|June 19, 2017
Effect of TLR ligands co-encapsulated with multiepitopic antigen in nanoliposomes targeted to human DCs via Fc receptor for cancer vaccinesFelix Rueda, Christina Eich, Begoña Cordobilla, et al.
Molecules (Basel, Switzerland)|May 15, 2019
ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-PresentationLuis J Cruz, Paul J Tacken, Johan M S van der Schoot, et al.
Pageof 2